Commonwealth Equity Services’s T2 Biosystems, Inc TTOO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-34
Closed -$19K 3825
2022
Q3
$19K Buy
34
+10
+42% +$6.58K ﹤0.01% 3587
2022
Q2
$19K Hold
24
﹤0.01% 3575
2022
Q1
$62K Buy
24
+6
+33% +$12.7K ﹤0.01% 3559
2021
Q4
$46K Buy
18
+6
+50% +$20.9K ﹤0.01% 3546
2021
Q3
$56K Hold
12
﹤0.01% 3492
2021
Q2
$73K Hold
12
﹤0.01% 3437
2021
Q1
$96K Hold
12
﹤0.01% 3271
2020
Q4
$71K Buy
12
+1
+9% +$6.12K ﹤0.01% 3105
2020
Q3
$77K Buy
11
+3
+38% +$22.2K ﹤0.01% 2914
2020
Q2
$53K Hold
8
﹤0.01% 2844
2020
Q1
$27K Buy
8
+6
+300% +$24.9K ﹤0.01% 2736
2019
Q4
$13K Sell
2
-1
-33% -$9.45K ﹤0.01% 2863
2019
Q3
$32K Buy
+3
New +$24.1K ﹤0.01% 2771

Other funds holding TTOO

Commonwealth Equity Services's TTOO Position: Q4 2022 in Review

Commonwealth Equity Services sold out of T2 Biosystems, Inc (TTOO) in Q4 2022, closing a stake of 34 shares — an estimated $19K sold.

Commonwealth Equity Services first reported a position in TTOO in Q3 2019 and held it in 13 quarters. The position peaked at $96K in Q1 2021. 20 funds tracked by Wall St. Rank hold TTOO as of Q4 2022.

  • Commonwealth Equity Services reported no remaining T2 Biosystems, Inc position as of Q4 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 34 T2 Biosystems, Inc shares in Q4 2022, an estimated $19K.
  • Commonwealth Equity Services first reported a position in T2 Biosystems, Inc in Q3 2019 and held it in 13 quarters.
  • Commonwealth Equity Services's T2 Biosystems, Inc position peaked at $96K in Q1 2021.
  • 20 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2022.

Based on Commonwealth Equity Services's 13F filing for Q4 2022, filed 7 Feb 2023.